TCT 2015 gives us an opportunity to network, share expertise, learn about the latest innovations in interventional cardiology and – you won’t want to miss this – hear a speech by Arnold Schwarzenegger!
As you decide what TCT 2015 sessions to participate in, events to attend, and technology partners to visit, consider this: as the number of physicians with access to robotically assisted vascular procedures has increased so has the complexity of the cases that they have successfully completed. We see changes in the expectations of the interventional community about radiation safety practices in the cath lab, robotic precision in manipulating wires and devices and, most recently, the value of robotic technology in complex PCIs. For example, robotic technology has been used successfully in cases that include:
- Triple vessel disease with a total occlusion of the left anterior descending (LAD) artery;
- Complex double balloon PTCA / LAD stent case;
- High risk Impella-supported cases;
- PCI and stenting of OM2 in setting of acute myocardial infarction (AMI); and
- RCA occlusion with downstream disease.
Just as in manual cases, multiple devices often needed in these cases can be easily integrated with and exchanged for other devices when utilizing the CorPath System. Sitting down, shielded from scatter radiation is a vast improvement from standing with heavy lead personal protective equipment for an extended period of time. This is especially true in more complex procedures which tend to be longer and can involve added radiation exposure. Sitting down at a remote workstation reduces radiation exposure and may reduce the risk of musculoskeletal injuries.
At the end of the day, it’s all about your patients’ and your own health. We invite you to stop by Corindus booth #1525 at TCT 2015 and learn more about how the CorPath Vascular Robotic System can be used in complex PCIs to enhance procedural precision while reducing the risk of occupational hazards for you and your colleagues.